Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01891747
Title A Phase I Study of High-dose L-methylfolate in Combination With Temozolomide and Bevacizumab in Recurrent High Grade Glioma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Vanderbilt-Ingram Cancer Center
Indications

malignant astrocytoma

oligodendroglioma

brain oligodendroglioma

brain glioblastoma multiforme

glioblastoma

Therapies

Bevacizumab + Temozolomide

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST